Dr. Matthew G. Kelling, DO

Dr. Kelling practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Kelling's NPI, 1144725144, was assigned on March 29, 2018. Dr. Kelling holds Kansas license 05-49400.

Dr. Kelling's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Kelling's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Kelling is also affiliated with Stormont Vail Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Kelling to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelling practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kelling's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Kelling's licenses on file in 2 states: Kansas and Missouri.

CMS data shows 555 Medicare services from Dr. Kelling across 9 procedure codes in 2024, for 440 Medicare patients. Medicare paid $17,911 for them.

CMS counts 440 Medicare patients who saw Dr. Kelling in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelling's median patient age at 72, with 51% women.

In 2024, Dr. Kelling wrote 87 Medicare Part D claims for 47 patients. 75% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $10,459 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kelling for performance year 2024, reported through an alternative payment model (APM). Dr. Kelling accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Kelling, published from 2019 to 2024. 2022 was the busiest year, with 2. Dr. Kelling has published most often in Am Heart J Plus. Dr. Kelling's most frequent co-authors are James R. Clugston, MD, Osama Dasa, MD and Katherine McCown Edenfield, MD.

CMS Open Payments shows 63 general payments to Dr. Kelling from 11 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 53% of the total. Abbott Laboratories paid the most, $2,294.